Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cis-urocanic acid in moderate or severe atopic dermatitis
NCT01320579Phase 2Completed
- Sponsor
- BioCis Pharma
- Start
- Mar 2011
- Primary completion
- Jun 2012
- Countries
- 1
01
Overview
A Phase 2 trial of cis-Urocanic acid in atopic dermatitis (AD), sponsored by BioCis Pharma. Started Mar 2011; status: completed.
02
Drugs
cis-Urocanic acid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01320579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320579.